Drug Error Reporting
Contents |
error or hazard to ISMP. If you are a CONSUMER, please click on the orange button below if you are ready to report an error or hazard. If you are medication error reporting form a HEALTHCARE PRACTITIONER, you can report the error or hazard to ISMP using one medication error reporting procedure of two secure methods: 1) Report to the ISMP National Medication Errors Reporting Program (MERP) or the ISMP National Vaccine Errors
Medication Error Reporting Format
Reporting Program (VERP) These are confidential, voluntary reporting programs operated by ISMP to learn about the causes of medication and vaccine errors. After you submit a report, ISMP staff will follow up with you to ask
Medication Error Reporting Categories
additional questions to clarify what went wrong and to identify the causes and factors that contributed to the reported event. The report will also be forwarded in confidence to the US Food and Drug Administration (FDA) and, when applicable, to product vendors to inform them about pharmaceutical labeling, packaging, and nomenclature issues that may cause errors by their design. Your name, contact information, and location will NOT be submitted to FDA medication error reporting and prevention or product vendors without your permission, and identifiable information will NOT be disclosed outside of ISMP. Click on the appropriate button below if you are ready to report an error or hazard to the ISMP MERP or ISMP VERP. Click here to learn more about ISMP reporting programs. 2) Report an adverse event to ISMP as a Patient Safety Organization (PSO) You may prefer to report an adverse medication or vaccine event to ISMP as a federally certified Patient Safety Organization (PSO). As a PSO, federal legal protection can be provided for certain patient safety information prepared within your patient safety evaluation system and submitted to ISMP. The protected information, called patient safety work product, includes information you provide about why the error happened or why the hazard exists, along with any further analysis of the event provided back to you by ISMP. The basic facts, whether written or observed, regarding what happened along with the patient’s medical/health records, are NOT considered patient safety work product and cannot be provided with federal protection in the event of a lawsuit. However, contextually identifiable information will NOT be disclosed outside ISMP unless we are legally compelled to do so. Click on the appropriate button below if you are ready to report
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug Safety and Availability
Medication Error Reporting A Survey Of Nursing Staff
Medication Errors Medication Errors Related to Drugs Share Tweet Linkedin Pin it More medication error reporting flow chart sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the Division of medication error reporting policy procedure Medication Error Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council for Medication Error Reporting and https://www.ismp.org/orderforms/reporterrortoismp.asp Prevention (NCCMERP) definition of a medication error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; http://www.fda.gov/drugs/drugsafety/medicationerrors/ dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to address safety issues resulting from the name confusion errors.DMEPA also works closely with federal partners, patient safety organiz
DataSetsGEO ProfilesGSSGTRHomoloGeneMedGenMeSHNCBI Web SiteNLM CatalogNucleotideOMIMPMCPopSetProbeProteinProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMedPubMed HealthSNPSRAStructureTaxonomyToolKitToolKitAllToolKitBookToolKitBookghUniGeneSearch termSearch Browse Titles Limits Advanced Help NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.Hughes RG, https://www.ncbi.nlm.nih.gov/books/NBK2652/ editor. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Apr. Patient Safety and Quality: An Evidence-Based Handbook for Nurses.Show http://www.medsiq.org/categories/drug-error-reporting detailsHughes RG, editor.Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Apr.ContentsSearch term < PrevNext > Chapter 35Error Reporting and DisclosureZane Robinson Wolf; Ronda G. Hughes.Author InformationZane Robinson error reporting Wolf;1 Ronda G. Hughes.21 Zane Robinson Wolf, Ph.D., R.N., F.A.A.N., dean and professor, La Salle University School of Nursing and Health Sciences. E-mail: ude.ellasal@flow2 Ronda G. Hughes, Ph.D., M.H.S., R.N., senior health scientist administrator, Agency for Healthcare Research and Quality. E-mail: vog.shh.qrha@sehguH.adnoRBackgroundThis chapter examines reporting of health care errors (e.g., verbal, written, or other form of communication and/or recording medication error reporting of near miss and patient safety events that generally involves some form of reporting system) and these events’ disclosure (e.g., communication of errors to patients and their families), including the ethical aspects of error-reporting mechanisms. The potential benefits of intrainstitutional and Web-based databases might assist nurses and other providers to prevent similar hazards and improve patient safety. Clinicians’ fears of lawsuits and their self-perceptions of incompetence could be dispelled by organizational cultures emphasizing safety rather than blame. This chapter focuses on the assertion that reporting errors that result in patient harm as well as seemingly trivial errors and near misses has the potential to strengthen processes of care and improve the quality of care afforded patients.Reporting ErrorsReporting errors is fundamental to error prevention. The focus on medical errors that followed the release of the Institute of Medicine’s (IOM) report To Err Is Human: Building a Safer Health System1 centered on the suggestion that preventable adverse events in hospital were a leading cause of death in the United States. This report emphasized findings from the Harvard Med
can be certain that current error reporting significantly underestimates the rates of medication error, not least because many errors are likely unknown to both healthcare workers and patients. Standardising error reporting and involving patients and carers in this process may help to improve our understanding of drug errors. Case study Find out about the Yellow Card Scheme here Projects Junior Doctor Led and Owned Patient Safety– Medication Error Reduction in an acute tertiary neurosciences wardEngaging the junior doctor workforce in implementing/ sustaining culture change and learning/ feedback among peers in a safe, facilitated environment. Read more Tools Medication Error Reporting & Prevention ToolThe Making it Safer Together (MiST) Collaborators identified this tool as a useful solution to providing a simple, accurate repeatable measure of the harm that arises from medication incidents. Read more Paediatric Prescribing Error: an Audit ToolWe developed this tool to assess and categorise prescribing errors occurring in the Neonatal Intensive Care Unit (NICU).Read more Medication Incident Operational Definition DRUG-gle (Druggle) Submit a resource Resource Name * Organisation * Type Project Tool E-learning Leave this field blank Related news 15 Jun 2016Resources Marketplace - JuneSafe prescribingDrug error reportingSupporting patients 14 Apr 2016Get Inspired - Learnings from the Champions NetworkDrug error reporting 14 Apr 2016Resources Marketplace Drug error reportingMedicine reconciliation More News Terms & Conditions Copyright © Meds IQ 2016